58221-U

SUPELCOSIL^™ LC-CN (5 µm) HPLC Columns

L × I.D. 15 cm × 4.6 mm, HPLC Column

• Synonyme(s) : COLONNE HPLC MTO-SUPELCOSIL^™ LC-CN 3UM 15CMX4.6MM
• Code UNSPSC : 41115700
• eCl@ss : 32110501
• Nomenclature NACRES : SB.52

Propriétés

• Product Name: Colonne HPLC SUPELCOSIL^™ LC-CN, 5 μm particle size, L × I.D. 15 cm × 4.6 mm
• Matériaux: stainless steel column
• Niveau de qualité: 100
• Agence: suitable for USP L10
• Gamme de produits: SUPELCOSIL^™
• Caractéristiques: endcapped
• Conditionnement: 1 ea of
• Ampleur du marquage: 4% Carbon loading
• Paramètres: ≤70 °C temp. range
• Technique(s): HPLC: suitable
• L × D.I.: 15 cm × 4.6 mm
• Superficie: 170 m²/g
• Couverture de surface: surface coverage 3.5 μmol/m²
• Matrice: silica gel, spherical particle platform; fully porous particle
• Groupe de la matrice active: cyano phase
• Taille des particules: 5 μm
• Dimension de pores: 120 Å
• Plage de pH: 2-7.5
• Technique de séparation: hydrophilic interaction (HILIC); normal phase; reversed phase

Description

Description générale

La phase LC-CN est souvent utilisée à la place de la silice parce qu′elle offre les avantages d′une phase gréffée (telle qu′une équilibration rapide, et une sensibilité moindre aux faibles variations de concentration en eau de la phase mobile). Plus souvent, néanmoins, les colonnes LC-CN sont utilisées avec des phases mobiles de phase inverse.

Application

• Validated Simple HPLC-UV Method for Mycophenolic Acid (MPA) Monitoring in Human Plasma. Internal Standardization: : This study presents a validated HPLC-UV method for monitoring mycophenolic acid in human plasma. The research highlights the necessity and efficiency of internal standardization in achieving accurate measurements. (Kunicki PK et al., 2021).


• An Improved HPLC Method for Therapeutic Drug Monitoring of Daunorubicin, Idarubicin, Doxorubicin, Epirubicin, and Their 13-dihydro Metabolites in Human Plasma.: This paper describes an enhanced HPLC method for monitoring therapeutic levels of several chemotherapeutic agents and their metabolites in human plasma, improving the accuracy and reliability of drug monitoring. (Fogli S et al., 1999).


• Analysis of Diltiazem and Desacetyldiltiazem in Serum by High-Performance Liquid Chromatography.: This research focuses on an HPLC method for analyzing diltiazem and its primary metabolite in serum, providing a robust tool for clinical pharmacokinetic studies. (Paczkowski D et al., 1995).


• High-Performance Liquid Chromatographic Method for the Determination of Eclanamine and Its N-Desmethyl and N,N-Didesmethyl Metabolites in Urine.: The study details a high-performance liquid chromatographic method for determining eclanamine and its metabolites in urine, crucial for pharmacokinetic and toxicological analysis. (Lakings DB et al., 1988).

Produits recommandés

Discover LiChropur reagents ideal for HPLC or LC-MS analysis

Informations légales

SUPELCOSIL is a trademark of Sigma-Aldrich Co. LLC